Please provide your email address to receive an email when new articles are posted on . “The most important finding of the trial is the nepafenac Evolute patients had a significantly higher percentage ...

Completion of Facility Enables Initiation of Phase 3 Clinical Trial of Nepafenac in Patients Undergoing Cataract Surgery AUSTIN, Texas, Sept. 12, 2023 /PRNewswire/ -- Mati Therapeutics Inc. ("Mati") ...

VANCOUVER, British Columbia, Feb. 9, 2011 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") today announced results from a Phase II proof-of-concept clinical trial for the ...

A retrospective administrative claims analysis of treatment options for dry eye disease (DED) evaluated treatment patterns and utilization characteristics of patients receiving cyclosporine, punctal ...

QLT Inc. announced results of its phase II clinical study on the efficacy and safety of the Latanoprost Punctal Plug Delivery System (LPPDS) in subjects with Ocular Hypertension (OH) and Open-Angle ...

Lacrimal drainage plugs improve the signs and symptoms of moderate dry eye and are well tolerated in eyes that do not benefit from topical lubrication, according to 27 level 2 and 3 studies culled ...

AUSTIN, Texas, Sept. 12, 2023 /PRNewswire/ -- Mati Therapeutics Inc. ("Mati") announced that it has completed and now occupies a facility dedicated to manufacturing all products formulated in Mati's ...